Table 2.

univariate analytical study of prognostic factors

Prognostic factors	Group with and without prognostic factor	Alive	Dead	P value
Type of IFI*	IA:14	7	7	0.573
	Fongemia:13	7	6
Sex	Male:14	6	8	0.043
	Female:15	9	6
Age	<65 years: 28	15	13	0.19
	≥65 years: 1	0	1
Hemopathy	AML: 16	9	7	0.265
	ALL: 6	4	2
	Lymphoma: 3	1	2
	Medullary aplasia: 3	0	3
	Multiple myeloma: 1	1	0
Disease status	Complete remission: 6	4	2	0.038
	Partial remission: 3	3	0
	Relapse/progression: 12	3	9
	Active disease: 8	5	3
Neutropenia	Yes: 27	13	14	0.259
	No: 2	2	0
Depth of neutropenia	<500: 16	7	9	0.358
	500-1000: 1	1	0
	>1000: 1	0	1
Duration of neutropenia	≥3 weeks: Yes: 9	2	7	0.041
	No: 9	6	3
Broad-spectrum Antibiotic therapy	Yes: 17	8	9	0.5
	No: 9	5	4
Parenteral nutrition	Yes: 12	5	7	0.297
	No: 17	10	7
Corticosteroid therapy	Yes: 8	6	2	0.155
	No: 20	9	11
Renal failure	Yes: 4	15	10	0.042
	No: 25	0	4
Extended stay in the hematology department	Yes: 20	9	11	0.25
	No: 9	6	3
Central venous catheter	Yes: 11	6	5	0.558
	No: 18	9	9
Prophylactic antifungal treatment	Yes: 9	3	6	0.048
	No: 17	10	7
Time to start antifungal treatment (days)	Average for living: 0.67	15	-	0.016
	Average among decedents: 2.07	-	14
Thrombocytopenia	Yes: 22	11	11	0.4
	No: 6	4	2
Lactate level (mmol/l)	Average for living: 1.67	10	-	0.035
	Average among decedents:3.14	-	14
Procalcitonin level (ng/ml)	Average for living:5.30	10	-	0.043
	Average among decedents:7.79	-	13
Fibrinogen level (g/l)	Average for living:3.46	8	-	0.048
	Average among decedents:4.23	-	11

^*For the type of IFIs, neuromeningeal cryptococcosis and pulmonary mucormycosis were excluded from the list to avoid biasing the calculation.